TITLE

2011 - CABG added no benefit to medical therapy for preventing death in coronary artery disease with heart failure

AUTHOR(S)
Flather, Marcus; Pepper, John
PUB. DATE
August 2011
SOURCE
ACP Journal Club;8/16/2011, Vol. 155 Issue 2, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on a study by Velazquez E. J. and colleagues focusing on the effectiveness of coronary artery bypass grafting (CABG) plus medical therapy in the treatment of patients suffering from coronary artery disease (CAD) and left ventricular (LV) systolic dysfunction. As stated, the study by Velazquez and colleagues did not show a reduction in the primary outcome of all-cause mortality from CABG in patients.
ACCESSION #
65456925

 

Related Articles

  • STICH: CABG plus medical therapy yields marginal benefit in patients with HF, CAD.  // Cardiology Today;May2011, Vol. 14 Issue 5, p1 

    This article discusses a study on the benefit of the addition of coronary artery bypass graft (CABG) to a regimen of optimal medical therapy in patients with heart failure (HF) and coronary artery disease.

  • No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial.  // MD Conference Express;May2011, p20 

    The article focuses on the Surgical Treatment of Ischemic Heart Failure (STICH) trial. The trial reveals that no mortality benefit from coronary artery bypass grafting (CABG) in addition to intensive guideline-based medical therapy compared with medical therapy alone. The STICH trial was...

  • 2011 - CABG added no benefit to medical therapy for preventing death in coronary artery disease with heart failure. Flather, Marcus; Pepper, John // ACP Journal Club;8/16/2011, Vol. 155 Issue 2, p8 

    Question In patients with coronary artery disease (CAD) and left ventricular (LV) systolic dysfunction, how effective is coronary artery bypass grafting (CABG) plus medical therapy compared with medical therapy alone for preventing death? Methods Design Randomized controlled trial (Surgical...

  • Clinical evidence versus patients' perception of coronary revascularization. Kawasuji, Michio // Surgery Today;Apr2013, Vol. 43 Issue 4, p347 

    Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have been developed as revascularization techniques for coronary artery disease. CABG offers a survival advantage over medical therapy, especially for high-risk coronary patients, whereas PCI is the most frequent...

  • Medical Therapy vs CABG in Patients with LV Dysfunction. Boyle, Andrew J. // Clinical Cardiology Alert;Jun2011, Vol. 30 Issue 6, p41 

    In this article, the author discusses a study by E. J. Velazquez and colleagues, which revealed that coronary-artery bypass graft (CABG) surgery reduces the risk of death from cardiovascular causes or hospitalization in significant coronary artery disease (CAD) and left ventricular (LV)...

  • Indication for Mitral Valve Repair with CABG. Crawford, Michael H. // Clinical Cardiology Alert;7/1/2012, p49 

    The author discusses a trial by Surgical Treatment for Ischemic Heart Failure (STICH), which concluded that adding mitral valve (MV) repair to coronary artery bypass grafting surgery (CABG) in patients with left ventricular (LV) dysfunction and moderate-to-severe mitral regurgitation (MR) may...

  • Undertreatment of coronary heart disease in patients undergoing coronary artery bypass surgery. Sambu, N.; Wald, D. S.; Seddon, M.; Simpson, I. A. // Heart;May2006, Vol. 92 Issue 5, p697 

    The article presents a study on the undertreatment of coronary heart disease in patients undergoing coronary artery bypass surgery (CABG). The aim of the study was to examine the use of medical treatments by patients undergoing CABG or angioplasty to see whether they were receiving adequate...

  • Cardiovascular highlights from non-cardiology journals. Bradley, Steven M. // Heart;Jan2015, Vol. 101 Issue 1, p82 

    The article discusses two studies related to cardiovascular disease published in non-cardiology journals in 2014 issues. The first study that appeared in "Lancet," focuses on assessing the benefits of beta-blockade treatment in heart failure with concurrent atrial fibrillation. Another study...

  • Surgical ventricular reconstruction -- no additional benefit to coronary bypass surgery alone. Sisu, Roxana // Maedica - a Journal of Clinical Medicine;2009, Vol. 4 Issue 2, p179 

    The article provides information on the study that determines the benefits of surgical ventricular reconstruction in patients with heart failure and coronary artery disease. It indicates that there is no significant difference in the primary outcomes causing death or hospitalization for...

  • Strategies for Multivessel Revascularization in Patients with Diabetes. Farkouh, Michael E.; Domanski, Michael; Sleeper, Lynn A.; Siami, Flora S.; Dangas, George; Mack, Michael; Yang, May; Cohen, David J.; Rosenberg, Yves; Solomon, Scott D.; Desai, Akshay S.; Gersh, Bernard J.; Magnuson, Elizabeth A.; Lansky, Alexandra; Boineau, Robin; Weinberger, Jesse; Ramanathan, Krishnan; Sousa, J. Eduardo; Rankin, Jamie; Bhargava, Balram // New England Journal of Medicine;12/20/2012, Vol. 367 Issue 25, p2375 

    Background: In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics